Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Giordanetto, F.
Right arrow Articles by Kroemer, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giordanetto, F.
Right arrow Articles by Kroemer, R. T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Protein Engineering, Vol. 15, No. 9, 727-737, September 2002
© 2002 Oxford University Press

Prediction of the structure of human Janus kinase 2 (JAK2) comprising JAK homology domains 1 through 7

Fabrizio Giordanetto1 and Romano T. Kroemer1,2,3

1 Department of Chemistry, Queen Mary and Westfield College,University of London, Mile End Road, London E1 4NS, UK

A theoretical model of human Janus kinase 2 (JAK2) comprising all seven Janus homology domains is presented. The model was generated by application of homology modelling approaches. The three-dimensional structure contains, starting from the N-terminus, FERM (4.1, ezrin, radixin, moesin), SH2 (Src homology region 2), tyrosine kinase-like, and tyrosine kinase domains. The predicted inter-domain orientation in JAK2 is discussed and the currently existing mutational data for Janus kinases are evaluated. Structural details of the SH2 and the FERM domains are presented. The predictions indicate that the SH2 domain is not fully functional. A number of hydrophobic amino acids of the FERM domain that are predicted to be involved in the constitutive association with the cytokine receptors are highlighted. The model gives new insights into the structure–function relationship of this important protein, and areas that could be investigated by mutation studies are highlighted.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Exp. Med.Home page
E. Flex, V. Petrangeli, L. Stella, S. Chiaretti, T. Hornakova, L. Knoops, C. Ariola, V. Fodale, E. Clappier, F. Paoloni, et al.
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia
J. Exp. Med., April 14, 2008; 205(4): 751 - 758.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Funakoshi-Tago, S. Pelletier, H. Moritake, E. Parganas, and J. N. Ihle
Jak2 FERM Domain Interaction with the Erythropoietin Receptor Regulates Jak2 Kinase Activity
Mol. Cell. Biol., March 1, 2008; 28(5): 1792 - 1801.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Haan, C. Margue, A. Engrand, C. Rolvering, H. Schmitz-Van de Leur, P. C. Heinrich, I. Behrmann, and C. Haan
Dual Role of the Jak1 FERM and Kinase Domains in Cytokine Receptor Binding and in Stimulation-Dependent Jak Activation
J. Immunol., January 15, 2008; 180(2): 998 - 1007.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Colaizzo, L. Amitrano, G. L. Tiscia, E. Grandone, M. A. Guardascione, and M. Margaglione
A new JAK2 gene mutation in patients with polycythemia vera and splanchnic vein thrombosis
Blood, October 1, 2007; 110(7): 2768 - 2768.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Nirmala, S. Dahl, B. J. Steffenson, C. G. Kannangara, D. von Wettstein, X. Chen, and A. Kleinhofs
Proteolysis of the barley receptor-like protein kinase RPG1 by a proteasome pathway is correlated with Rpg1-mediated stem rust resistance
PNAS, June 12, 2007; 104(24): 10276 - 10281.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
L. M. Scott, W. Tong, R. L. Levine, M. A. Scott, P. A. Beer, M. R. Stratton, P. A. Futreal, W. N. Erber, M. F. McMullin, C. N. Harrison, et al.
JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis
N. Engl. J. Med., February 1, 2007; 356(5): 459 - 468.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. Ishida-Takahashi, F. Rosario, Y. Gong, K. Kopp, Z. Stancheva, X. Chen, E. P. Feener, and M. G. Myers Jr.
Phosphorylation of jak2 on ser523 inhibits jak2-dependent leptin receptor signaling.
Mol. Cell. Biol., June 1, 2006; 26(11): 4063 - 4073.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. S. Lucet, E. Fantino, M. Styles, R. Bamert, O. Patel, S. E. Broughton, M. Walter, C. J. Burns, H. Treutlein, A. F. Wilks, et al.
The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor
Blood, January 1, 2006; 107(1): 176 - 183.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
M. Pesu, J. O'Shea, L. Hennighausen, and O. Silvennoinen
Identification of an Acquired Mutation in Jak2 Provides Molecular Insights into the Pathogenesis of Myeloproliferative Disorders
Mol. Interv., August 1, 2005; 5(4): 211 - 215.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. S. Argetsinger, J.-L. K. Kouadio, H. Steen, A. Stensballe, O. N. Jensen, and C. Carter-Su
Autophosphorylation of JAK2 on Tyrosines 221 and 570 Regulates Its Activity
Mol. Cell. Biol., June 1, 2004; 24(11): 4955 - 4967.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. P. Feener, F. Rosario, S. L. Dunn, Z. Stancheva, and M. G. Myers Jr.
Tyrosine Phosphorylation of Jak2 in the JH2 Domain Inhibits Cytokine Signaling
Mol. Cell. Biol., June 1, 2004; 24(11): 4968 - 4978.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. He, X. Wang, J. Jiang, R. Guan, K. E. Bernstein, P. P. Sayeski, and S. J. Frank
Janus Kinase 2 Determinants for Growth Hormone Receptor Association, Surface Assembly, and Signaling
Mol. Endocrinol., November 1, 2003; 17(11): 2211 - 2227.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.